These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3260336)

  • 21. Use of Haemophilus polysaccharide vaccine in a rural clinic setting.
    Ross SA; Darby CP; Harvell J; Watson C
    J S C Med Assoc; 1988 Mar; 84(3):105-8. PubMed ID: 3258942
    [No Abstract]   [Full Text] [Related]  

  • 22. Haemophilus influenzae type b disease in an Amish population: studies of the effects of genetic factors, immunization, and rifampin prophylaxis on the course of an outbreak.
    Granoff DM; McKinney T; Boies EG; Steele NP; Oldfather J; Pandey JP; Suarez BK
    Pediatrics; 1986 Mar; 77(3):289-95. PubMed ID: 3485275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hib vaccine is available and soon to be required.
    Kelley MF
    Tex Med; 1991 Jan; 87(1):8. PubMed ID: 1998163
    [No Abstract]   [Full Text] [Related]  

  • 24. Haemophilus influenzae type b polysaccharide vaccine.
    Cates KL
    Pediatr Ann; 1986 Jun; 15(6):461-3, 467-8. PubMed ID: 3523406
    [No Abstract]   [Full Text] [Related]  

  • 25. AAFP recommendations: new Haemophilus influenzae type b immunization schedule. The Commission on Public Health and Scientific Affairs.
    Am Fam Physician; 1991 Apr; 43(4):1437-40. PubMed ID: 2008824
    [No Abstract]   [Full Text] [Related]  

  • 26. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
    CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591
    [No Abstract]   [Full Text] [Related]  

  • 27. The launch of an infant Haemophilus influenzae type B immunization programme in Iceland.
    Olafsson O; Jónsdóttir KE; Barreto L; Hansen H; Sigthorsson T
    Arctic Med Res; 1991; Suppl():341-3. PubMed ID: 1365148
    [No Abstract]   [Full Text] [Related]  

  • 28. Hib immunisation catch up programme in North East Thames.
    O'Brien H
    Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R17-8. PubMed ID: 7511460
    [No Abstract]   [Full Text] [Related]  

  • 29. Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines.
    Schneerson R; Robbins JB; Barrera O; Sutton A; Habig WB; Hardegree MC; Chaimovich J
    Prog Clin Biol Res; 1980; 47():77-94. PubMed ID: 6970933
    [No Abstract]   [Full Text] [Related]  

  • 30. Failures after immunization with Haemophilus influenzae type b vaccines--1991-1995.
    Scheifele D; Gold R; Marchessault V; Duclos P
    Can Commun Dis Rep; 1996 Feb; 22(3):17-20, 23. PubMed ID: 8822260
    [No Abstract]   [Full Text] [Related]  

  • 31. Haemophilus influenzae type b polysaccharide vaccines.
    Granoff DM; Cates KL
    J Pediatr; 1985 Sep; 107(3):330-6. PubMed ID: 3897497
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration.
    Fernandez J; Levine OS; Sanchez J; Balter S; LaClaire L; Feris J; Romero-Steiner S
    J Infect Dis; 2000 Nov; 182(5):1553-6. PubMed ID: 11023481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of Haemophilus influenzae type b polysaccharide vaccine.
    Granoff DM; Osterholm MT
    Pediatrics; 1987 Oct; 80(4):590-2. PubMed ID: 3498928
    [No Abstract]   [Full Text] [Related]  

  • 34. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(11):170-4, 179-80. PubMed ID: 3081787
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of previous infection on antibody response of children to vaccination with capsular polysaccharide of Haemophilus influenzae Type b.
    Norden CW; Michaels RH; Melish M
    J Infect Dis; 1975 Jul; 132(1):69-74. PubMed ID: 1080178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type b.
    Glezen WP; Englund JA; Siber GR; Six HR; Turner C; Shriver D; Hinkley CM; Falcao O
    J Infect Dis; 1992 Jun; 165 Suppl 1():S134-6. PubMed ID: 1588147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA workshop on Haemophilus b polysaccharide vaccine--a preliminary report.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Aug; 36(32):529-31. PubMed ID: 3112543
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of Haemophilus influenzae type b capsular polysaccharide vaccine on the incidence of epiglottitis and meningitis.
    Peltola H; Virtanen M; Mäkelä PH
    Pathol Biol (Paris); 1983 Feb; 31(2):141-3. PubMed ID: 6341944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report.
    Lepow ML; Gold R
    N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.